Company Updates

ASX ANNOUNCEMENT Folkestone Funds Management (Folkestone) is pleased to announce that the Folkestone Real Estate Income Fund at Wollongong (Fund) closed for applications approximately 50 per cent oversubscribed. Folkestone’s Managing Director, Mr Greg Paramor said, “the success of the capital raising demonstrates that investors continue to seek investments with strong income returns and quality covenants.  The […]

The Information Memorandum (“IM”) dated 1 July 2013 is issued by Independent Reserve P/L [ACN 164 257 069]. Please register your interest to receive a copy of the IM. Click on the FOLLOW button.

Relivit has extended its offer for raising capital to end on 31 August 2013. The company has released a Supplementary Offer Document to describe the company’s recent achievements, as well as describing the terms of the extended offer. This document can be downloaded atwww.assob.com.au/REL Relivit has raised almost $700,000 of capital in 2013, and will shortly […]

Source: The Sydney Morning Herald By: Lawrence Money There is fresh hope for Tasmanian devils, with a new drug treatment showing dramatic improvements in facial tumours that are destroying the marsupials’ population. Trials by a Tasmanian government research team using a drug called EBC-46 slowed the growth of tumours in four captive devils in a […]

PERTH, AUSTRALIA: 01 July 2013 – Phylogica Ltd (ASX: PYC, XETRA: PH7), a leading Australian peptide drug discovery company, announced today the expansion of its collaboration with Janssen Biotech, Inc. (“Janssen”) to discover, develop and commercialise new classes of peptide drug conjugates derived from Phylogica’s Phylomer drug discovery platform. Phylogica has received an undisclosed payment […]